ScholarIQanswers from OpenAlex

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer

PaperCitations, authors & open-access status

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer have?

ScholarIQcitation count

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer has 17 citations in the OpenAlex counts ScholarIQ stores.

When was Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer published?

ScholarIQyear

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer has 2020 year in the ScholarIQ index.

What is the open-access status of Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer?

ScholarIQoa status

Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer has closed oa status in the ScholarIQ index.

What is the DOI of Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer?

ScholarIQdoi

The DOI for Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer is on the source record.

What is the PMID of Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer?

ScholarIQpmid

The PMID for Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer is on the source record.

What is the OpenAlex record for Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer?

ScholarIQopenalex

The OpenAlex for Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial